Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor

Circulation Research

Volumn 90, Issue 2, 2002, Pages 135-142

  Thomas, Walter G ^a   Brandenburger, Yves ^a   Autelitano, Dominic J ^a   Pham, Thao ^a   Qian, Hongwei ^a   Hannan, Ross D ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Adenovirus; Angiotensin; AT1A receptor; Cardiomyocyte hypertrophy; EGF receptor transactivation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ADENOVIRUS VECTOR; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ATRIAL NATRIURETIC FACTOR; BISINDOLYLMALEIMIDE; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA CONTENT; FIBROBLAST; GENE EXPRESSION REGULATION; HEART HYPERTROPHY; HEART VENTRICLE REMODELING; IMMEDIATE EARLY GENE; NEWBORN; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSACTIVATION; VIRUS INFECTION; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CELLS, CULTURED; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENETIC VECTORS; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 0037040165     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh0202.104109     Document Type: Article

References (42)

1. International union of pharmacology: XXIII, the angiotensin II receptors
2. The role of protein kinases in adaptational growth of the heart
3. Prevention of cardiac hypertrophy by calcineurin inhibition: Hope or hype?
4. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
5. Angiotensin II stimulates ERK via two pathways in epithelial cells: Protein kinase C suppresses a G protein-coupled receptor-EGF receptor transactivation pathway
6. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor
7. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
8. Signaling in myocardial hypertrophy: Life after calcineurin?
9. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension
10. The cardiac renin-angiotensin system: Conceptual, or a regulator of cardiac function?
11. Overexpression of angiotensin II type 1 receptor in cardiomyocytes induces cardiac hypertrophy and remodeling
12. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes
13. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: Evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes
14. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-β1 and endothelin-1 from fibroblasts
15. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes
16. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats
17. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy
18. Alterations of angiotensin II receptor contents in hypertrophied hearts
19. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction
20. 2 receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death
21. A simplified system for generating recombinant adenoviruses
22. 1A) receptor carboxyl terminus: A role in receptor endocytosis
23. Increased expression of UBF is a critical determinant for rRNA synthesis and hypertrophic growth of cardiac myocytes
24. Ras-dependent signaling by the GTPase-deficient mutant of Gα12
25. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy
26. A nuclear pathway for α1-adrenergic receptor signaling in cardiac cells
27. Overexpression of the transcription factor UBF1 is sufficient to increase ribosomal DNA transcription in neonatal cardiomyocytes: Implications for cardiac hypertrophy
28. Regulation of ribosomal DNA transcription during contraction-induced hypertrophy of neonatal cardiomyocytes
29. Transcriptional regulation of ribosomal RNA synthesis during growth of cardiac myocytes in culture
30. Selective activation of α1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of α1-adrenergic receptor subtype mRNAs
31. Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts
32. 2+ levels
33. Transactivation: A novel signaling pathway from angiotensin II to tyrosine kinase receptors
34. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
35. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype
36. 2+-dependent signaling
37. Protein kinase C, but not tyrosine kinases or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes
38. Role of transactivation of the EGF receptor in signaling by G-protein-coupled receptors
39. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: Roles of phospholipid-derived second messengers
40. Role of calcium-sensitive tyrosine kinase Pyk2/CAKβ/RAFTK in angio-tensin II induced Ras/ERK signaling
41. Activation of MAPKs by angiotensin II in vascular smooth muscle cells: Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK
42. 2 receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation